Ethyl pyruvate pretreatment attenuates concanavalin A-induced autoimmune hepatitis in mice

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Shen, Miao ^a   Lu, Jie ^a   Cheng, Ping ^a   Lin, Chunlei ^a   Dai, Weiqi ^a   Wang, Fan ^a   Wang, Chengfen ^a   Zhang, Yan ^a   Chen, Kan ^a   Xu, Ling ^a   Zhou, Yinqun ^a   Guo, Chuanyong ^a  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CONCANAVALIN A; ETHYLPYRUVATE; HIGH MOBILITY GROUP B1 PROTEIN; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE HEPATITIS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ANIMALS; BLOTTING, WESTERN; CONCANAVALIN A; DRUG-INDUCED LIVER INJURY; HEPATITIS, AUTOIMMUNE; HMGB1 PROTEIN; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-2; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; MITOGENS; NF-KAPPA B; PYRUVATES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84894611536     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087977     Document Type: Article

References (36)

1. Tiegs G, Hentschel J, Wendel A (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90: 196-203.
2. Kusters S, Gantner F, Kunstle G, Tiegs G (1996) Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111: 462-471. (Pubitemid 26256736)
3. Pisetsky DS (2013) The Translocation of Nuclear Molecules During Inflammation and Cell Death. Antioxid Redox Signal.
4. Tiegs G (2007) Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury. Z Gastroenterol 45: 63-70.
5. Schwabe RF, Brenner DA (2006) Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 290: G583-589.
6. Zhou Y, Dai W, Lin C, Wang F, He L, et al. (2013) Protective effects of necrostain-1 against concanavalin A-induced acute hepatic injury in mice. Mediators Inflamm 706156. doi: 10.1155/2013/706156. Epub 2013 Oct 1.
7. Tang D, Kang R, Zeh HJ, 3rd, Lotze MT (2011) High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal 14: 1315-1335.
8. Nogueira-Machado JA, de Oliveira Volpe CM (2012) HMGB-1 as a target for inflammation controlling. Recent Pat Endocr Metab Immune Drug Discov 6: 201-209.
9. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251. (Pubitemid 29329996)
10. Kim S, Kim SY, Pribis JP, Lotze M, Mollen KP, et al. (2013) Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14. Mol Med 19: 88-98.
11. Rosas-Ballina M, Goldstein RS, Gallowitsch-Puerta M, Yang L, Valdes-Ferrer SI, et al. (2009) The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE. Mol Med 15: 195-202.
12. Kang R, Tang D, Schapiro NE, Loux T, Livesey KM, et al. (2013) The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Oncogene.
13. Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, et al. (2004) Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 170: 1310-1316. (Pubitemid 39657195)
14. Andrassy M, Volz HC, Schuessler A, Gitsioudis G, Hofmann N, et al. (2012) HMGB1 is associated with atherosclerotic plaque composition and burden in patients with stable coronary artery disease. PLoS One 7: e52081.
15. Zhou RR, Liu HB, Peng JP, Huang Y, Li N, et al. (2012) High mobility group box chromosomal protein 1 in acute-on-chronic liver failure patients and mice with ConA-induced acute liver injury. Exp Mol Pathol 93: 213-219.
16. Tong H, Tang Y, Chen Y, Yuan F, Liu Z, et al. (2013) HMGB1 activity inhibition alleviating liver injury in heatstroke. J Trauma Acute Care Surg 74: 801-807.
17. Watanabe T, Kubota S, Nagaya M, Ozaki S, Nagafuchi H, et al. (2005) The role of HMGB-1 on the development of necrosis during hepatic ischemia and hepatic ischemia/reperfusion injury in mice. J Surg Res 124: 59-66. (Pubitemid 40269802)
18. Gong Q, Zhang H, Li JH, Duan LH, Zhong S, et al. (2010) High-mobility group box 1 exacerbates concanavalin A-induced hepatic injury in mice. J Mol Med (Berl) 88: 1289-1298.
19. Tang D, Kang R, Xiao W, Zhang H, Lotze MT, et al. (2009) Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function. Am J Respir Cell Mol Biol 41: 651-660.
20. Li W, Ashok M, Li J, Yang H, Sama AE, et al. (2007) A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1. PLoS One 2: e1153.
21. Tu CT, Yao QY, Xu BL, Wang JY, Zhou CH, et al. (2012) Protective effects of curcumin against hepatic fibrosis induced by carbon tetrachloride: modulation of high-mobility group box 1, Toll-like receptor 4 and 2 expression. Food Chem Toxicol 50: 3343-3351.
22. Fink MP (2007) Ethyl pyruvate: a novel anti-inflammatory agent. J Intern Med 261: 349-362.
23. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, et al. (2002) Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A 99: 12351-12356.
24. Luan ZG, Zhang H, Ma XC, Zhang C, Guo RX (2012) Therapeutic treatment with ethyl pyruvate attenuates the severity of liver injury in rats with severe acute pancreatitis. Pancreas 41: 729-737.
25. Xu XH, Chen Q, Chen Y, Lv LX, Zhu CQ, et al. (2010) [Effect of ethyl pyruvate on expression of inflammatory factors and mitogen-activated protein kinase proteins in renal ischemic/reperfusion injury in BABL/c mice]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 22: 750-753.
26. Wang LW, Wang LK, Chen H, Fan C, Li X, et al. (2012) Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats. World J Gastroenterol 18: 5709-5718.
27. Beasley RP, Lin CC, Chien CS, Chen CJ, Hwang LY (1982) Geographic distribution of HBsAg carriers in China. Hepatology 2: 553-556.
28. Sass G, Heinlein S, Agli A, Bang R, Schumann J, et al. (2002) Cytokine expression in three mouse models of experimental hepatitis. Cytokine 19: 115-120. (Pubitemid 35216191)
29. Zhang X, Wei HX, Rui S, Wei H, Tian Z (2010) Opposite effects of high and low doses of interleukin-2 on T cell-mediated hepatitis in mice (interleukin-2 on hepatitis). Hepatol Int 4: 641-648.
30. Nakamura K, Okada M, Yoneda M, Takamoto S, Nakade Y, et al. (2001) Macrophage inflammatory protein-2 induced by TNF-alpha plays a pivotal role in concanavalin A-induced liver injury in mice. J Hepatol 35: 217-224. (Pubitemid 32803477)
31. Wolf D, Hallmann R, Sass G, Sixt M, Kusters S, et al. (2001) TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1-relevance for concanavalin A-induced hepatitis. J Immunol 166: 1300-1307. (Pubitemid 32060291)
32. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, et al. (2000) High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192: 565-570. (Pubitemid 30666257)
33. Yasuda T, Ueda T, Shinzeki M, Sawa H, Nakajima T, et al. (2007) Increase of high-mobility group box chromosomal protein 1 in blood and injured organs in experimental severe acute pancreatitis. Pancreas 34: 487-488. (Pubitemid 46725797)
34. Huang JM, Hu J, Chen N, Hu ML (2013) Relationship between plasma high-mobility group box-1 levels and clinical outcomes of ischemic stroke. J Crit Care 28: 792-797.
35. Sawa H, Ueda T, Takeyama Y, Yasuda T, Shinzeki M, et al. (2006) Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. World J Gastroenterol 12: 7666-7670. (Pubitemid 46040580)
36. Wang CM, Jiang M, Wang HJ (2013) Effect of NF-kappa B inhibitor on high-mobility group protein B 1 expression in a COPD rat model. Mol Med Res 7(2): 499-502.